Abstract-Adenosme mhlblts rat vascular smooth muscle cell (SMC) growth However, the effects of adenosme on human vascular SMC prohferahon and synthesis of extracellular matnx protems, such as collagen, are unknown
S mooth muscle cells (SMCs) importantly contribute to the pathophyslology of vascular remodellmg Induced by hypertension, atherosclerosis and restenosls by prohferatmg, nugratmg into the mtlma, and depositing extracellular matrix @CM) proteins, such as collagen ' Endogenous factors that are generated m substantial amounts locally by the cells w&m the vessel wall, le, endothehal cells, SMCs, and fibroblasts, and that mhlbtt SMC nqratlon, growth, and ECM production may play a major vasoprotective role m preventmg vascular remodehng
In this regard, adenosme may be an important factor Vascular SMCs,' fibroblasts,3 cardlomyocytes,4 and endothehal cells, both vascular' and cardiac," have several metabolic pathways for generating large amounts of adenosme Moreover, we have recently shown that vascular SMCs can also synthesize adenosme from exogenous cAh4P ' Taken together, these findings suggest that substantial amounts of adenosme are synthesized locally within the vessel wall, thus assunng pharmacologlcally active levels of adenosme m the vasculature Since both exogenous and SMC-denved adenosme inhibits fetal calf serum (FCS)-induced growth of rat aortlc SMCs,**'s we hypothesize that adenosme may smularly protect against vasooccluslve disorders m humans by regulating SMC growth and mamtammg vascular homeostasls Accordmgly, the suns of the present study were to determme (1) whether exogenous adenosme l&bits prol&eration and collagen synthesis by human aomc SMCs (HASMCs), (2) whether specific adenosme receptor subtype(s) are involved m medlatmg any inhibitory effects of adenosme on prohferanon and collagen synthesis by HASMCs, (3) whether HASMCs synthesize adenosine, and (4) whether HASMC-denved adenosme can effectively inhibit prohferation and collagen synthesis by HASMCs Materials Methods Dulbecco's Modified Eagle Medium (DMEM), DMEM/F12 medlum, Hanks' Balanced Salt Solution (HBSS), pemclllm, streptomycm, 0 25% trypsln-EDTA solution, and all tlssue culture ware were purchased from GIBCO FCS was obtamed from HyClone Laboratones Inc Adenosme, 2-chloroadenosme (Cl-Ad), erythro-9-(2-hydroxy-3-nonyl) ademne hydrochloride (EHNA), and dlpyndamole (DIP), were purchased from Sigma Chemical Co 
Cl-Ad (an analog of adenosme that 1s not metabolized and mediates its effects via both A, and AZ receptors'O), (3) CPA (an adenosme agonist that mediates its effects selectively via A, receptors"'), (4) CGS21680
(an adenosme agomst that mediates its effects selectively via AIA receptors'"),
NECA (an adenosme agonist that mehates Its effects via both A, and A, receptors"),
MECA (an adenosme agonist with affimty for both A, and A, receptors3), Fig 1A) . FCS (2.5%) induced proliferation (cell number) ofgrowth-arrested HASMCs by 9-fold to 11-fold (X.05; data not shown). Adenosine and Cl-Ad inhibited FCS-induced increase in cell number in a concentration-dependent manner (Fig 1B; K.05 ). Similar to the effects on DNA synthesis, Cl-Ad, the stable analog of adenosine, was more potent in inhibiting cell proliferation as compared to adenosine (X.05). The lowest concentrations of adenosine and Cl-Ad which inhibited cell proliferation were O.lnmol/L.
Treatment with 2.5% FCS stimulated proline incorporation by h-fold to &fold (X.001 versus 0.25% FCS; data not shown). Treatment of HASMCs with adenosine (lOpmol/L) and Cl-Ad (lOpmol/L) inhibited FCS-induced proline incorporation ( Fig  1C; X.05). Compared with adenosine, Cl-Ad was more potent in inhibiting FCS-induced proline incorporation (Fig 1C; X.05 ).
As shown in Fig 2A, the inhibitory effects of adenosine on DNA synthesis were significantly enhanced in presence of EHNA, and EHNA and ID0 significantly increased the recovery of exogenous adenosine added to the medium (Fig 2B) . Moreover, in HASMCs treated with EHNA plus IDO, almost all of the exogenously added adenosine was recovered in the medium (Fig 2B) .
Treatment of quiescent HASMCs with EHNA, DIP, and ID0 inhibited FCS-induced thymidine incorporation and cell number in a concentration-dependent manner (Fig 3; PC.001 ). The lowest concentrations of EHNA, DIP, and ID0 that significantly inhibited FCS-induced thymidine incorporation were lOpmol/L, ,001 pmol/L, and ,001 pmol/L, respectively. A 50% decrease in FCS (2.50/o)-induced thymidine incorporation by EHNA, DIP, and ID0 was observed at z 50/J,mol/L, 0.5 pmol/L, and 0.5 pmol/L, respectively. Similar to DNA synthesis and cell number, treatment of HASMCs with EHNA, IDO, and DIP significantly inhibited FCS-induced proline incorporation (Fig 4C) . EHNA significantly enhanced the inhibitory effects of DIP and ID0 on FCS-induced thymidine incorporation (Fig 4A) , cell number (Fig 4B) , and proline incorporation (Fig 4C) . ID0 significantly increased the inhibitory effects of DIP on thymidine incorporation, cell number, and proline incorporation. Moreover, in HASMCs treated with EHNA (lOpmol/L) plus ID0 (lpmol/L) plus DIP (O.lpmol/L), FCS-induced thymidine and proline incorporation and cell number were reduced to almost basal levels (Fig 4A, 4B and 4C) .
In samples drawn at time zero, adenosine levels were nondetectable; however, the levels of adenosine were significantly increased in the medium of HASMCs collected after 4 hours of incubation and were 4.8?0.5nmol/L/lO"cells (P-C.001). Treatment of HASMCs with EHNA significantly increased the levels of adenosine in the medium to 89+8 nmol/L/106cells (P<.OOl), an increase of G 1800% (Fig 4D) . Similar to EHNA, treatment of HASMCs with DIP and ID0 also increased the levels of adenorme in the medium (PC.05; Fig 4D) the levels were also increased dramatically but were comparable to those observed in HASMCs treated with EHNA+IDO (Fig 4D) . High (10e4 mol/L), but not low, concentrations of CPA inhibited FCS-induced thymidine incorporation (Fig 5) and cell proliferation (Fig 5) . CGS21680 had little effect on FCS-induced thymidine incorporation and cell proliferation. NECA was more potent than CPA but less potent than Cl-Ad in inhibiting FCS-induced thymidine incorporation (Fig 5) and cell proliferation (Fig 5) . MECA was more potent than NECA, CPA, and CGS21680 and as potent as Cl-Ad in inhibiting FCS-induced thymidine incorporation and cell proliferation.
Cl-Ad inhibited thymidine incorporation and cell proliferation by 50% at a concentration of 5 and 1 Fmol/L, respectively. At this concentration, CGS21680, CPA, NECA, and MECA inhibited DNA synthesis by approximately 6%, 21%, 28% and 50%, respectively.
With respect to the effects on collagen synthesis, we compared the effects of equimolar concentrations (10 pmol/L) ofadenosine, Cl-Ad, CGS21680, CPA, NECA and MECA. Concentrations at which CPA and CGS21680 mediate receptor-specific pharmacological actions (1 nmol/L) did not inhibit FCS-induced collagen synthesis. However, lOpmol/L of CPA and CGS21680 inhibited FCS-induced collagen synthesis (Fig 5) . As compared to CGS21680 and CPS, NECA (10 pmol/L) was more potent in inhibiting collagen synthesis; however, it was significantly less potent than Cl-Ad and MECA, which inhibited collagen synthesis by 41% and 38%, respectively (Fig 5C) .
KF17837 and DPSPX, but not DPCPX, significantly reversed the inhibitory effects of Cl-Ad on FCS-induced thymidine (Fig 6; Pc.05) and proline (Fig 6; JV.05 effects of EHNA, DIP, and ID0 on FCS-induced thymidine and proline incorporation were significantly attenuated by KF17837 and DPSPX, but not by DPCPX (Fig 7) .
To confima that cell-death did not occur during various treatments and did not contribute to the observed inhibitory effects of the agents used in this study, trypan blue exclusion tests were carried out. At the concentrations used in this study, there was no loss in viability of cells treated with the various agents.
Discussion
The present study demonstrates that adenosine inhibits FCSinduced growth of HASMCs. Treatment of HASMCs with adenosine, with a stable adenosine analog (Cl-Ad), and with agents that elevate endogenous adenosine (EHNA, IDO, DIP) inhibit FCS-induced DNA synthesis, collagen synthesis, as well as cell proliferation. The inhibitory effects of adenosine are mimicked by MECA and partially by NECA, an adenosine agonists with affinity for both A, and Aa receptors,'" but not by the adenosine agonists CPA and CGS21680, which are selective A, and AaA receptor agonists," respectively. Thus, the inhibitory effects of adenosine are possibly mediated via A,, receptors and not via A, or AaA receptors. Furthermore, the inhibitory effects of Cl-Ad, EHNA, DIP, and ID0 were significantly reversed by KF17837, a selective A, receptor antagonist,3 and by DPSPX, an A,/A, receptor antagonist," but not by DPCPX, a selective A, receptor antagonist.'" Our findings provide the first evidence that exogenous as well as HASMC-derived adenosine inhibits HASMC growth and collagen synthesis via the Aa8 receptor.
Our observation that CPA (an adenosine analog which is highly selective for A, receptors'" and mediates its effects at pharmacologically low doses [lo-' mol/L and lower]) was unable to inhibit FCS-induced growth and collagen synthesis by 
